than 15 years, but a clear role for them in the man agement of neurosurgical patients has not been es tablished. Initially, concern about the potential risks of studies that employed intracarotid injection may have limited their application. Less invasive methods that employ inhalation or intravenous in jection of xenon-133 have now been developed, but the equipment and expertise required to measure CBF are still to be found in only a minority of neurosurgical departments. As measurements of cerebrovascular function by more complex methods such as emission tomography and X-ray transmis sion tomography begin to be applied to clinical problems, it is timely to ask if measurements of ce rebral blood flow can contribute to neurosurgical practice and to consider whether principles have already emerged that can serve to direct future studies. In particular, are there circumstances in which CBF measurements have broken what Las sen referred to in these columns as the "magical barrier from clinical research to clinical useful ness. "
The earliest, and one of the clearest, illustrations of a practical application of cerebral blood flow measurement was in the prediction of the outcome of carotid ligation. This operation was once widely used in the treatment of aneurysms of the internal carotid artery. The problem was that some patients were unable to compensate adequately for the re duction in flow that followed carotid ligation and developed a hemiplegia or other ischaemic compli cations. This often happened after a delay of 12-24 h and was therefore not detected for 20-30 min by the standard practice of trial ligation under local anaesthesia. Measurements of CBF with intraca rotid xenon-l33 administration before and after trial carotid clamping made it possible to identify pa tients liable to develop ischaemia (Jennett et aI., 1966) . Permanent surgical ligation could thus be avoided in the patients at risk, and a large series 357 of patients was treated by ligation with low mor bidity (Miller et aI., 1977) .
Although advances in intracranial microsurgery
have led to carotid ligation now being used in frequently, several lessons can be learned from these early studies. First, blood flow was deter mined not only under basal conditions, but also after a stimulus that posed some stress on the re serve of the cerebral circulatory system. Second, blood flow measurements were not used to diagnose established ischaemia, but to predict the risk of its It is now well recognised that an isolated mea surement of cerebral blood flow provides little use ful information about the state of the cerebral cir culation in any given state of health or disease. In stead, the cerebral circulation should be stressed in some way, in order to measure its ability to respond to changing physiological conditions. Cerebrovas cular responsiveness can be assessed with relatively simple, inexpensive equipment, even a single de tector, and there is renewed promise that this sim ple approach can still provide clinicians with useful information. Recently, interest has returned to the identification of patients with subarachnoid haemorrhage whose cerebral circulatory reserve is inadequate. The focus now is on the identification, either before or during operation, of patients liable to develop delayed cerebral ischaemia after an in tracranial operation for a ruptured aneurysm.
Intra-operative measurements of CBF with an intravenous xenon-133 method have identified a group of patients whose cerebral blood flow falls substantially with hypotensive anaesthesia and who subsequently go on to develop delayed cerebral is chaemic neurological deficits (Pickard et aI., 1980; Farrar et aI., 1981) . These observations are in ac cordance with previous anecdotal experience, namely, that patients who did not tolerate ligation 358 G. TEASDALE AND D. MENDELOW were also at risk from intracranial surgery. What needs to be discovered is if blood flow mea surements performed before operation can reliably identify the patients at risk during intracranial surgery. This information might then influence de cisions about the timing of the operation and type of anaesthesia used. There is also renewed interest in the use of induced hypertension post -operatively.
In a small group of patients this has been reported to increase cerebral blood flow and to reverse neurological deficits associated with delayed cere bral ischaemia (Symon et aI., 1978) . Although the demonstration of regional cerebral blood flow abnormalities has been reported to be a useful indication that a patient is likely to benefit from extracranial/intracranial arterial bypass (Schmiedek et aI., 1976) , others have found that blood flow measurements alone do not correlate with clinical outcome after this procedure (Podreka et aI., 1981) .
Cerebral blood flow measurements can be useful in predicting the risk of future ischaemia, but they have less to offer in the diagnosis of ischaemia that has already occurred or is developing. Several studies have shown that cerebral function fails and ischaemic brain damage develops only after blood flow falls below certain critical levels. In clinical practice, the ischaemic episode is usually so short lived that it is almost impossible to "capture" the moment of ischaemia with a blood flow measure ment. It is therefore unlikely that measurements of cerebral blood flow can ever be made sufficiently frequently for the technique to be useful as a monitor of the development of cerebral ischaemia outside the operating room.
Greater use of cerebral blood flow measurements for per-operative monitoring will depend on the availability of methods for the rapid analysis of data so that a result is available to surgeons or anaesthetists within minutes of the study. A more practically acceptable method for per-operative monitoring may be in the assessment of brain func tion by electrophysiological techniques (elec troencephalography, sensory evoked potentials, di rect cortical response, central conduction time), Several of these can now be recorded more or less continuously. Although changes usually occur only when CBF is reaching critical levels, electrophys iological methods may provide a useful "last-min ute" warning of impending ischaemic brain damage.
Clinicians are often faced with studying the con sequences of an ischaemic episode from which a patient has survived, Some of the disenchantment with the determination of cerebral blood flow in clinical practice may stem from the problems that are inherent in measurements made when the brain is already damaged. When this has happened, the blood-brain partition co-efficient for the tracer may change, compartmental methods of analysis may become invalid, and for well-recognised technical reasons, It IS difficult or impossible to detect lo calised regions of impaired blood flow. The com mon finding in clinical studies in patients with intra cranial lesions such as head injury or spontaneous intracranial haemorrhage has been a reduction in the basal level of blood flow. Usually the degree of reduction in cerebral blood flow simply parallels the reduction in consciousness, and it is the oc casional divergence between clinical state and blood flow findings that promises to be of most interest.
For example, if a patient is neurologically well after a subarachnoid haemorrhage but shows a low blood flow, this may reflect severe cerebral arterial spasm. In such patients it may be advisable to de lay intracranial surgery (Ferguson et aI., 1981a) .
In head injury, on the other hand, there is a group of children whose blood flow is relatively high, de spite their being in profound coma with high intra cranial pressure (Bruce et aI., 1981) .
A major problem in the investigation of estab lished brain damage is to decide whether an ob served reduction in cerebral blood flow represents a primary mechanism, i.e., denoting damage to the brain as a result of ischaemia, or whether it is simply a response to the reduced metabolic needs of dam aged brain. The development of tomographic mea surements for mapping blood flow, oxygen utilisa tion, and oxygen extraction may allow the detection of areas in which cerebral blood flow has fallen to critical levels (" misery perfusion") (Lenzi et aI., 1981) . On the other hand, it remains to be seen how common these are, for how long they persist, and if the information can usefully influence management.
There is abundant evidence that in people who die after head injury or spontaneous intracranial haemorrhage, the brain has most frequently been damaged by a diffuse impairment of cerebral blood flow. We suggest that the factor that has restricted the contribution of cerebral blood flow measure ment to clinical neurosurgical practice has not been the limited focal resolution of available two dimensional methods, but a failure either to ask or to obtain answers to appropriate questions. The key to improved clinical results lies in the devising of tests to identify patients whose cerebral circulatory reserve, although impaired, has not yet become critically exhausted. These patients might then be treated in ways that either avoid such stresses as hypoxia and hypotension or that increase the ca pacity of the cerebral circulation available to cope with adverse changes. The new tomographic meth ods remain subject to many of the same practical limitations as previous isotope-based methods but may make it more feasible to map disturbances of cerebral blood flow and to correlate these with other derangements in cerebrovascular function or metabolism. Nevertheless, efforts should still be focussed upon preventing ischaemic brain damage, rather than expecting clinical returns from the in vestigation of patients already suffering from estab lished ischaemic lesions.
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